CTOs on the Move


 
FinPay, LLC provides Patient Financial Management Solutions to assist healthcare providers in their strategy to manage the $400 billion in patient out-of-pocket medical expenses that has caused a massive spike in bad debt and lost revenue to providers nationwide. The continuing shift of financial responsibility to the patient for the cost of healthcare has forced healthcare providers to rethink their Patient Financial Management strategy. FinPay`s solution provides: 1. Financial Clearance Policies that target and segment patients that pose a high financial risk to the provider and customized work flow for these high risk patients. 2. Patient engagement at the point ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.finpay.net
  • 700 South Henderson Road Suite 202
    King of Prussia, PA USA 19406
  • Phone: 855.434.6729

Executives

Name Title Contact Details
Joe Coyne
Chief Technology Officer Profile

Similar Companies

Targeted Medical Pharma

Targeted Medical Pharma Inc. is a leader in the development of therapeutic systems for the nutritional management of chronic diseases. The Company strives to optimize patient care with safe and clinically effective prescription Medical Food products, as well as distributing generic and branded drugs.

Le Tourneau Prosthetics

Le Tourneau Prosthetics is a Beaumont, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Molecular Bio-Products

Molecular Bio-Products is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VTS Medical Systems

VTS Medical Systems is a Melville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fresenius Kabi

Fresenius Kabi is a global health care company that specializes in lifesaving medicines and medical technologies for infusion, transfusion and clinical nutrition. Our expansive portfolio of products and global network of science and manufacturing centers provide essential support for the care of critical and chronically ill patients. We are part of Fresenius SE, a health care group with more than 100 years of experience in pharmaceuticals, medical devices and life sciences. Our employees – more than 35,000 worldwide – develop and deliver injectable pharmaceuticals and infusion systems; blood collection, transfusion and cell technologies; and essential nutrients for parenteral nutrition. We have special expertise in medicines for oncology, infection, anesthesia, analgesia and critical care. Our products are used in all sites of care – from hospitals and clinics to blood and plasma centers, and increasingly in patients’ homes. In biosimilars, we are developing products with a focus on oncology and autoimmune diseases.